The ups and downs of the M&A and financing markets over the past few years, particularly in the emerging companies (EC) and venture capital (VC) sector, have demonstrated the importance of emerging ...
In biotechnology, timing is everything. Whether advancing a novel therapy or scaling a platform, companies often reach a pivotal point: go public or sell. Increasingly, biotech executives are choosing ...
A lot of scientific and popular decision-making literature is couched in a dual-process model [1]. The dual-process model pits the relatively automatic, heuristic-driven, and unconscious System 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results